Signal #128713 · SEC 8-K

$ODTX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ODTX filing catalyst

Why did $ODTX trigger an AI stock catalyst alert?

$ODTX triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -0.5/10). Headline: Odyssey Therapeutics Q3 Net Loss Widens to $53.1M; Cash Runway to 2H 2028. Key points: - Net loss widened to $53.1M in Q3 2026 vs $35.5M in Q3 2025; adjusted net loss at $41.9M - R&D expenses increased to $42.1M driven by pipeline progression - Cash and equivalents stand at $387M, sufficient to fund operations into 2H 2028

How did $ODTX stock react after the SEC filing?

After the SEC 8-K for $ODTX, observed market reaction: T0 price $21.57. Past moves do not guarantee future results.

Where can I get real-time $ODTX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ODTX via Telegram and the VIP Web Terminal from €10/month.

$ODTX

$ODTX – Odyssey Therapeutics Q3 Net Loss Widens to $53.1M; Cash Runway to 2H 2028

Odyssey Therapeutics, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $ODTX

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-0.5 / 10)

Net loss widened to $53.1M in Q3 2026 vs $35.5M in Q3 2025; adjusted net loss at $41.9M
R&D expenses increased to $42.1M driven by pipeline progression
Cash and equivalents stand at $387M, sufficient to fund operations into 2H 2028

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →